- Home
- LGND vs VCYT Comparison
LGND vs VCYT Comparison
Compare LGND & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- VCYT
- Stock Information
- Founded
- LGND 1987
- VCYT 2006
- Country
- LGND United States
- VCYT United States
- Employees
- LGND 68
- VCYT N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- VCYT Medical Specialities
- Sector
- LGND Health Care
- VCYT Health Care
- Exchange
- LGND Nasdaq
- VCYT Nasdaq
- Market Cap
- LGND 2.2B
- VCYT 2.1B
- IPO Year
- LGND 1992
- VCYT 2013
- Fundamental
- Price
- LGND $139.02
- VCYT $23.34
- Analyst Decision
- LGND Strong Buy
- VCYT Buy
- Analyst Count
- LGND 8
- VCYT 9
- Target Price
- LGND $144.71
- VCYT $39.89
- AVG Volume (30 Days)
- LGND 139.7K
- VCYT 1.0M
- Earning Date
- LGND 08-05-2025
- VCYT 08-06-2025
- Dividend Yield
- LGND N/A
- VCYT N/A
- EPS Growth
- LGND N/A
- VCYT N/A
- EPS
- LGND N/A
- VCYT 0.41
- Revenue
- LGND $181,488,000.00
- VCYT $463,393,000.00
- Revenue This Year
- LGND $18.41
- VCYT $12.55
- Revenue Next Year
- LGND $18.87
- VCYT $9.79
- P/E Ratio
- LGND N/A
- VCYT $56.63
- Revenue Growth
- LGND 53.40
- VCYT 23.42
- 52 Week Low
- LGND $81.74
- VCYT $19.73
- 52 Week High
- LGND $129.90
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- LGND 75.81
- VCYT 29.95
- Support Level
- LGND $120.68
- VCYT $26.18
- Resistance Level
- LGND $126.24
- VCYT $27.91
- Average True Range (ATR)
- LGND 4.48
- VCYT 0.96
- MACD
- LGND 1.87
- VCYT -0.26
- Stochastic Oscillator
- LGND 96.06
- VCYT 0.00
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.